Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Unichem Laboratories Ltd
Quarter-by-quarter operating performance
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 402 | 423 | 416 | 466 | 432 | 483 | 507 | 533 | 587 | 527 | 579 | 521 | 575 |
| Expenses + | 386 | 395 | 407 | 435 | 406 | 443 | 452 | 448 | 503 | 504 | 513 | 476 | 527 |
| Operating Profit | 16 | 28 | 9 | 31 | 25 | 40 | 55 | 86 | 84 | 22 | 66 | 45 | 48 |
| OPM % | 4% | 7% | 2% | 7% | 6% | 8% | 11% | 16% | 14% | 4% | 11% | 9% | 8% |
| Other Income + | -28 | 9 | 6 | 79 | -119 | 4 | 9 | 14 | 9 | 7 | -37 | 287 | 11 |
| Interest | 6 | 6 | 7 | 6 | 5 | 4 | 5 | 7 | 5 | 7 | 8 | 7 | 9 |
| Depreciation | 30 | 29 | 29 | 32 | 27 | 32 | 32 | 31 | 30 | 32 | 31 | 31 | 31 |
| Profit before tax | -47 | 2 | -22 | 73 | -126 | 8 | 27 | 62 | 58 | -9 | -11 | 293 | 19 |
| Tax % | -6% | 132% | 12% | -0% | 3% | 74% | 9% | 6% | 8% | 16% | 10% | 10% | 42% |
| Net Profit + | -44 | -1 | -24 | 73 | -129 | 2 | 25 | 58 | 53 | -10 | -12 | 264 | 11 |
| EPS in Rs | -6.29 | -0.10 | -3.48 | 10.40 | -18.37 | 0.29 | 3.50 | 8.22 | 7.52 | -1.49 | -1.69 | 37.54 | 1.55 |
Financials of Unichem Laboratories Ltd
Annual income statement trend
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 1,202 | 1,333 | 698 | 815 | 1,180 | 1,104 | 1,235 | 1,270 | 1,343 | 1,785 | 2,111 | 2,202 |
| Expenses + | 1,100 | 1,169 | 738 | 942 | 1,254 | 1,153 | 1,144 | 1,198 | 1,389 | 1,698 | 1,846 | 2,018 |
| Operating Profit | 101 | 164 | -41 | -128 | -74 | -49 | 91 | 72 | -46 | 87 | 265 | 184 |
| OPM % | 8% | 12% | -6% | -16% | -6% | -4% | 7% | 6% | -3% | 5% | 13% | 8% |
| Other Income + | 20 | 15 | 184 | 2,735 | 91 | 91 | 50 | 47 | -0 | -26 | 35 | 265 |
| Interest | 3 | 3 | 3 | 8 | 8 | 8 | 5 | 6 | 17 | 23 | 21 | 32 |
| Depreciation | 41 | 39 | 44 | 51 | 67 | 82 | 84 | 91 | 113 | 123 | 125 | 125 |
| Profit before tax | 77 | 137 | 97 | 2,548 | -58 | -48 | 51 | 22 | -176 | -85 | 155 | 292 |
| Tax % | 3% | 21% | -12% | 0% | -59% | 25% | 33% | -50% | 15% | 10% | 11% | 14% |
| Net Profit + | 75 | 108 | 109 | 2,545 | -24 | -60 | 34 | 33 | -202 | -94 | 138 | 253 |
| EPS in Rs | 8.31 | 11.90 | 11.96 | 361.82 | -3.38 | -8.55 | 4.87 | 4.70 | -28.72 | -13.32 | 19.53 | 35.91 |
| Dividend Payout % | 24% | 17% | 25% | 1% | -118% | -47% | 82% | 85% | -14% | 0% | 0% | 0% |
Financials of Unichem Laboratories Ltd
Capital structure and asset base
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 18 | 18 | 18 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 |
| Reserves | 849 | 936 | 1,045 | 2,666 | 2,606 | 2,517 | 2,543 | 2,604 | 2,421 | 2,424 | 2,437 | 2,703 |
| Borrowings + | 22 | 36 | 98 | 151 | 200 | 206 | 119 | 349 | 314 | 248 | 460 | 500 |
| Other Liabilities + | 264 | 283 | 359 | 359 | 323 | 407 | 436 | 351 | 444 | 589 | 659 | 520 |
| Total Liabilities | 1,153 | 1,274 | 1,521 | 3,190 | 3,142 | 3,145 | 3,112 | 3,319 | 3,193 | 3,275 | 3,569 | 3,737 |
| Fixed Assets + | 416 | 403 | 491 | 578 | 810 | 870 | 884 | 990 | 1,257 | 1,252 | 1,300 | 1,213 |
| CWIP | 123 | 237 | 250 | 238 | 92 | 330 | 568 | 494 | 147 | 123 | 31 | 100 |
| Investments | 41 | 14 | 14 | 901 | 926 | 550 | 392 | 264 | 2 | 1 | 0 | 0 |
| Other Assets + | 574 | 620 | 766 | 1,473 | 1,313 | 1,395 | 1,269 | 1,571 | 1,787 | 1,898 | 2,239 | 2,425 |
| Total Assets | 1,153 | 1,274 | 1,521 | 3,190 | 3,142 | 3,145 | 3,112 | 3,319 | 3,193 | 3,275 | 3,569 | 3,737 |
Financials of Unichem Laboratories Ltd
Operating, investing and financing cash movement
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 78 | 112 | 68 | -112 | -328 | 20 | 33 | -260 | -85 | 14 | -7 | 4 |
| Cash from Investing Activity + | -52 | -85 | -132 | 1,648 | -286 | -36 | -66 | 100 | 241 | 63 | -242 | 192 |
| Cash from Financing Activity + | -51 | -33 | 59 | -881 | -2 | -62 | -121 | 191 | -81 | -106 | 184 | 2 |
| Net Cash Flow | -25 | -7 | -4 | 655 | -616 | -78 | -154 | 32 | 75 | -29 | -65 | 198 |
| Free Cash Flow | 4 | -28 | -79 | -271 | -519 | -360 | -254 | -386 | -123 | 0 | -142 | 163 |
| CFO/OP | 95% | 87% | -237% | 89% | 424% | -49% | 52% | -350% | 160% | 23% | 4% | 6% |
Financials of Unichem Laboratories Ltd
Working capital efficiency and return ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 58 | 60 | 165 | 124 | 135 | 129 | 74 | 142 | 160 | 131 | 135 | 137 |
| Inventory Days | 171 | 184 | 397 | 278 | 278 | 374 | 518 | 527 | 414 | 365 | 418 | 349 |
| Days Payable | 114 | 131 | 297 | 230 | 182 | 236 | 202 | 161 | 193 | 174 | 170 | 128 |
| Cash Conversion Cycle | 116 | 113 | 265 | 172 | 231 | 267 | 390 | 508 | 382 | 322 | 382 | 358 |
| Working Capital Days | 88 | 90 | 174 | 133 | 165 | 154 | 163 | 207 | 207 | 173 | 159 | 169 |
| ROCE % | 9% | 15% | 9% | 128% | -2% | -2% | 2% | 1% | -5% | -0% | 6% | 4% |